Structural optimization and prospect of constructing hemoglobin oxygen carriers based on hemoglobin
- PMID: 37809714
- PMCID: PMC10558499
- DOI: 10.1016/j.heliyon.2023.e19430
Structural optimization and prospect of constructing hemoglobin oxygen carriers based on hemoglobin
Abstract
The current global shortage of organ resources, the imbalance in donor-recipient demand and the increasing number of high-risk donors make organ preservation a necessity to consider appropriate storage options. The current method of use often has risks such as blood group mismatch, short shelf life, and susceptibility. HBOCs have positive effects such as anti-apoptotic, anti-inflammatory, antioxidant and anti-proliferative, which have significant advantages in organ storage. Therefore, it is the common pursuit of researchers to design and synthesize HBOCs with safety, ideal oxygen-carrying capacity, easy storage, etc. that are widely applicable and optimal for different organs. There has been a recent advancement in understanding HBOCs mechanisms, which is discussed in this review.
Keywords: Chemical modification; Hemoglobin-based oxygen carriers; Organs storage; Red blood cells.
© 2023 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures







Similar articles
-
Hemoglobin-Based Oxygen Carriers: Potential Applications in Solid Organ Preservation.Front Pharmacol. 2021 Nov 30;12:760215. doi: 10.3389/fphar.2021.760215. eCollection 2021. Front Pharmacol. 2021. PMID: 34916938 Free PMC article. Review.
-
Recent and prominent examples of nano- and microarchitectures as hemoglobin-based oxygen carriers.Adv Colloid Interface Sci. 2018 Oct;260:65-84. doi: 10.1016/j.cis.2018.08.006. Epub 2018 Aug 24. Adv Colloid Interface Sci. 2018. PMID: 30177214 Review.
-
Hemoglobin-based oxygen carriers camouflaged with membranes extracted from red blood cells: Optimization and assessment of functionality.Biomater Adv. 2022 Mar;134:112691. doi: 10.1016/j.msec.2022.112691. Epub 2022 Feb 3. Biomater Adv. 2022. PMID: 35581082
-
Pharmaceutical aspects of hemoglobin-based oxygen carriers.Curr Drug Deliv. 2005 Apr;2(2):133-42. doi: 10.2174/1567201053586029. Curr Drug Deliv. 2005. PMID: 16305414 Review.
-
Development of Time-course Oxygen Binding Analysis for Hemoglobin-based Oxygen Carriers.Anal Sci. 2017;33(8):953-956. doi: 10.2116/analsci.33.953. Anal Sci. 2017. PMID: 28794333
Cited by
-
Precise Engineering and Efficient Biosynthesis of Robust and High-Activity Human Haemoglobin for Artificial Oxygen Carriers.Microb Biotechnol. 2025 Mar;18(3):e70128. doi: 10.1111/1751-7915.70128. Microb Biotechnol. 2025. PMID: 40072822 Free PMC article.
References
-
- McFarlane L., Nelson P., Dugbartey G G., Sener A. Pre-Treatment of transplant donors with hydrogen sulfide to protect against warm and cold ischemia-reperfusion injury in kidney and other transplantable solid organs. Int. J. Mol. Sci. 2023;24(April):3518. doi: 10.3390/ijms24043518. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources